Line 440: | Line 440: | ||
<p> <a href="https://static.igem.org/mediawiki/2017/e/ee/T--Munich--protocol--au_np_cleavage.pdf" > Click here! </a> </p> | <p> <a href="https://static.igem.org/mediawiki/2017/e/ee/T--Munich--protocol--au_np_cleavage.pdf" > Click here! </a> </p> | ||
</object> | </object> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr><td colspan=6 align=center valign=center> | ||
+ | <h3>Cloning</h3> | ||
+ | <p> | ||
+ | We used different approaches to assemble genetic parts dependent on their design. Golden gate cloning was chosen for assembly of Cas13a-His-SUMO-Lwa into pSB1C3. We digested and ligated DNA parts of aeBlue to assemble this construct. For Intein-Extein we finally used a combination of different cloning methods to assembly the DNA fragments. </p> | ||
+ | <p> | ||
+ | We amplified DNA fragments with standard PCR approaches. We used Q5, Phusion and Taq polymerases. Cells were transformed by chemical or electro transformation and outgrown at 37 °C for 1 h in SOC medium before plating on selective LB agar plates. We isolated plasmid DNA with the help of a commercial available kit and always eluted with nuclease-free water. With analytical restriction digest, colony PCR and agarose gels we checked the success of our cloning work. Final glycerol cryo stocks were always verified by sequencing. | ||
+ | </p> | ||
</td> | </td> | ||
</tr> | </tr> |
Revision as of 14:49, 28 October 2017